Pharma IQ | 11/11/2010
Chris Jennison, Professor of Statistics at the University of Bath, talks to Helen Winsor from Pharma IQ, about adaptive and group sequential clinical methods for clinical trial design and how important group sequential design is to clinical trials. Jennison also shares his insights on the vital considerations in sample size re-estimation for updated estimates of response variance and where clinical trials headed in the future. Haven’t got the technology to l...
To continue reading this story Click Here
Upcoming Events
AI for Pharma & Healthcare
23 - 25 September, 2025
Amsterdam
Register Now |
View Agenda |
Learn More